Glenmark Pharmaceuticals

1439.75

+3.00 (0.21%) tick

BSE

Buy Sell

NSE BSE

Last updated on 21 May 2025 04:24 PM

Open Demat account

Returns

-0.25%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

40545.2

Earning Per Share

183.11

Dividend Yield

0.26%

P/E Ratio

5.23

P/B Ratio

1.69

Debt to Equity

0.10

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological ent... tity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets. The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology. Show more

Similar Companies

Sun Pharmaceutical

1731.8 +24.00 (0.01%) tick

1Yr Returns

+10.82%

Cipla

1482.4 +28.00 (0.02%) tick

1Yr Returns

+0.83%

Mankind Pharma Limited

2531.4 -17.80 (-0.01%) tick

1Yr Returns

+22.26%

Dr. Reddys Laboratories

1224.7 +0.50 (0.00%) tick

1Yr Returns

+5.9%

Lupin

1996 +29.10 (0.01%) tick

1Yr Returns

+16.8%